Inosine triphosphate pyrophosphatase activity as a potential predictor of methotrexate remission in juvenile idiopathic arthritis

Juvenile Idiopathic Arthritis

Cataract surgery with IOL implantation in children with chronic anterior uveitis associated with juvenile idiopathic arthritis (JIA) or antinuclear antibody (ANA)-positive uveitis: mid-term results and predictors for outcome

Am J Ophthalmol

Wortmann C, Backes J, Rothaus K, Kasper M, Lapp T, Heinz C, Heiligenhaus A

doi: 10.1016/j.ajo.2025.11.043

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Rheumatoid Arthritis

Infant-onset juvenile idiopathic arthritis - a multicenter retrospective study

Rheumatology (Oxford)

Strauss T, Klotsche J, Windschall D, Sprengel A, Krumrey-Langkammerer M, Dollinger S, Haas JP, Tenbrock K, Trauzeddel R, Girschick H, Heubner G, Oommen PT, Hufnagel M, Freudenhammer M, Dressler F, Raab A, Dückers G, Behrendes R, Klemann C, Jansson A, Horneff G, Klein A, Zimmer A, Hospach A, Kümmerle-Deschner J, Holl-Wieden A, Brück N, Minden K, Schuetz C, NPRD study group

doi: 10.1093/rheumatology/keaf586

Juvenile Idiopathic Arthritis

When to address fatigue in juvenile idiopathic arthritis during clinical visits based on the JAMAR

Rheumatology (Oxford)

Vroegindeweij A, Musterd SA, Nijhof SL, Consolaro A, Vastert SJ, De Roock S, Swart JF

doi: 10.1093/rheumatology/keaf325

Rheumatoid Arthritis

Towards the development of a definition of independence for individuals diagnosed with rheumatoid arthritis in remission: an 'OMERACT remission in rheumatoid arthritis patient perspective' special interest group report

Semin Arthritis Rheum

Gazel U, Barnes E, Jones B, Terrett A, Voshaar M, Hoogland W, March L, Beaton D, Khoo T, Chin A, Shea B, Tugwell P, Proudman S, Flurey CA

doi: 10.1016/j.semarthrit.2026.152948

Rheumatoid Arthritis

Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study

BMJ Open

Rayner F, Hiu S, Melville A, Bigirumurame T, Anderson A, Dyke B, Kerrigan S, McGucken A, Prichard J, Shahrokhabadi MS, Hilkens CMU, Buckley CD, McInnes IB, Ng WF, Goodyear C, Teare D, Filer A, Siebert S, Raza K, Pratt A, Baker KF, Isaacs J

doi: 10.1136/bmjopen-2024-092478

Juvenile Idiopathic Arthritis

Increased school absence among children with juvenile idiopathic arthritis - a national matched comparison study

J Rheumatol

Pedersen MJ, Høst C, Hansen SN, Klotsche J, Minden K, Deleuran B, Bech BH

doi: 10.3899/jrheum.2024-1182

Rheumatoid Arthritis

Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial

Lancet Rheumatol

De Marco G, Hensor EMA, Helliwell PS, Sultan S, Dubash SR, Michelena X, Coates LC, Emery P, Tan AL, McGonagle D, Marzo-Ortega H

doi: 10.1016/S2665-9913(25)00156-0

Rheumatoid Arthritis

Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm

Ann Rheum Dis

Hetland ML, Heiberg MS, Sokka-Isler T, Rudin A, Østergaard M, Haavardsholm E, Rutanen J, van Vollenhoven R, Grondal G, Ørnbjerg LM, Bøyesen P, Lampa J, Nurmohamed M, Gudbjornsson B, Uhlig T, Kononoff A, Lend K, Krabbe S, Olsen IC, Sexton J, Hørslev-Petersen K

doi: 10.1016/j.ard.2025.03.002

Related content

Cataract surgery with IOL implantation in children with chronic anterior uveitis associated with juvenile idiopathic arthritis (JIA) or antinuclear antibody (ANA)-positive uveitis: mid-term results and predictors for outcome

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Infant-onset juvenile idiopathic arthritis - a multicenter retrospective study

When to address fatigue in juvenile idiopathic arthritis during clinical visits based on the JAMAR

Towards the development of a definition of independence for individuals diagnosed with rheumatoid arthritis in remission: an 'OMERACT remission in rheumatoid arthritis patient perspective' special interest group report

Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study

Increased school absence among children with juvenile idiopathic arthritis - a national matched comparison study

Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial